X

WHY BLOOM BURTON & CO?
SERVICES
TRANSACTIONS
TEAM
EVENTS
News & Insights
CAREERS
CONTACT

•

M

E

N

U

•

May 1, 2015

Brian Bloom speaks to BNN about the state of biotech in Canada

As with all our posts, please see our legal disclaimer.

RELATED NEWS

The Bloom Burton funds are now available on Fundserv BNN Bloomberg | Moderna, Novavax have more upside potential than Big Pharma if vaccine is approved Bayer and Northpond Ventures Lead USD $55 Million Series A Financing Round for Triumvira Immunologics BNN Bloomberg | The States will be the first to market with a vaccine: Bloom Burton & Co ESSA Pharma Completes Public Offering for Aggregate Gross Proceeds of US$48,990,000 ESSA Pharma Announces Pricing of Public Offering of Common Shares BNN Bloomberg | Moderna vaccine wont hit market until 2021: Brian Bloom CanTech Letter | Newtopia has a huge upside, says Bloom Burton BNN Bloomberg | Top Canadian biopharma companies working to fight the spread of COVID-19 The Globe and Mail | Top Canadian biotech investor on the firms most likely to turn COVID-19 drug trials into treatments and when a vaccine may arrive

2020 BLOOM BURTON & CO DESIGNED & DEVELOPED BY THE TEAM AT PIXELCARVE MEMBER IIROC MEMBER CIPF PRIVACY POLICY COMPLAINT ACCESSIBILITY POLICY BUSINESS CONTINUITY PLAN LEGAL DISCLAIMER